NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 118 filers reported holding NUVALENT INC in Q3 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,943,622 | +17.6% | 1,260,466 | +7.9% | 0.00% | 0.0% |
| Q2 2023 | $49,254,096 | +81.0% | 1,167,989 | +12.0% | 0.00% | +50.0% |
| Q1 2023 | $27,217,166 | -45.1% | 1,043,203 | -37.4% | 0.00% | +100.0% |
| Q4 2022 | $49,616,338 | +766.2% | 1,666,096 | +465.5% | 0.00% | – |
| Q3 2022 | $5,728,000 | +48.5% | 294,632 | +3.6% | 0.00% | – |
| Q2 2022 | $3,856,000 | +22.6% | 284,359 | +25.6% | 0.00% | – |
| Q1 2022 | $3,145,000 | -1.9% | 226,439 | +34.4% | 0.00% | – |
| Q4 2021 | $3,207,000 | +2.4% | 168,453 | +21.3% | 0.00% | – |
| Q3 2021 | $3,132,000 | – | 138,911 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,884,492 | $75,256,396 | 12.94% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $93,331 | 11.66% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $521,565,816 | 11.63% |
| COMMODORE CAPITAL LP | 1,075,000 | $28,046,750 | 4.27% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 281,533 | $7,345,196 | 3.03% |
| Perceptive Advisors | 2,300,048 | $60,008,252 | 1.77% |
| Boxer Capital, LLC | 1,210,192 | $31,574 | 1.55% |
| Avoro Capital Advisors LLC | 1,888,888 | $49,281,088 | 0.73% |
| Soleus Capital Management, L.P. | 236,900 | $6,180,721 | 0.64% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,402,525 | $36,591,877 | 0.51% |